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Background: Malaria epidemiology in Madagascar is classified into four different areas, ranging from unstable
seasonal transmission in the highlands to hyperendemic perennial transmission areas in the costal level. Most
malaria studies in Madagascar are focused on symptomatic children. However, because of the low transmission in
some areas with correspondingly low level of semi-immunity, adults are also at risk, in particular pregnant women.
The objective of this study was to gain information on the genetic epidemiology of malarial infections in pregnant
women in order to provide information for malaria control and elimination programmes in Madagascar.
Methods: Between May and August 2010, we carried out cross-sectional surveys targeting healthy pregnant
women in six locations, three in the coastal area and three in the highlands at 850–1300 m. 1244 blood samples
were screened for anti-Plasmodium falciparum antibodies by immunofluorescence test and for malarial infection by
realtime-PCR. The prevalence of chloroquine and sulphadoxine-pyrimethamine resistance markers was also
determined in all Plasmodium falciparum samples by PCR-RFLP as well as the multiplicity of infection through
genotyping six neutral microsatellites.
Results: In the highlands, 67.4% of the women presented antibodies against Plasmodium falciparum and 9.2% were
carrying parasites, at the coast 95.6% and 14.8%, respectively. In the mean, 1.2 clones were detected in infected
pregnant woman in the highlands and 1.5 at the coast. A higher level of monoclonal infections was found in the
highlands (85.4%) compared to the coast (61.8%). Resistance markers for sulphadoxine-pyrimethamine were present
only in two sites.
Conclusion: Immunity is triggered in Malagasy highland populations when they are infected with malaria parasites,
but these populations could also serve as a reservoir for epidemics.
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Asymptomatic carriage of malaria parasites is common
in adults in endemic regions and provides a reservoir for
gametocytes, the forms of the parasite infectious to mos-
quitoes and thus responsible for cross-species transmis-
sion [1]. These asymptomatic carriers may be of particular
importance in the highland regions of Madagascar, where
malaria can be absent over years, but may reappear epi-
demically, like between 1986 and 1988 where malaria* Correspondence: maiga@bni-hamburg.de
1Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany
Full list of author information is available at the end of the article
© 2015 Maïga-Ascofaré et al.; licensee BioMed
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.outbreaks had devastating effects on a virtually non-
immune population [2,3]. Malaria parasites found on the
island of Madagascar are Plasmodium falciparum, Plas-
modium vivax and to a minor degree Plasmodium malar-
iae and Plasmodium ovale [4]. The main malaria vector in
the Madagascan highlands is Anopheles funestus that once
had disappeared after extensive insecticide spraying in the
1950s, but reappeared in the 1980s [5] leading to epide-
mics that caused several ten thousand of deaths in the
1980s and 1990s [6].
The country has been classified in four distinct malaria
epidemiologic zones based on the geography and theCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Map of Madagascar showing the six study locations with
their altitude. The red circles indicate the six study locations and the
purple square the capital Antananarivo. The black lines represent the
main roads for long distance travel.
Maïga-Ascofaré et al. Malaria Journal  (2015) 14:188 Page 2 of 9length and intensity of malaria transmission. Malaria
transmission is stable and perennial at the East Coast,
stable and long seasonal at the West Coast and unstable
and seasonal in the Central Highlands and the Semi-desert
zones of the South [4]. On the East and West Coast, expos-
ure and thus immunity among adults is reported to be high
and most morbidity and mortality is among children under
five and pregnant women. In the upper Central Highlands
and the South immunity is limited making the population
vulnerable to epidemics especially during the rainy season
(from late October/early November until May).
Since 2008, The National Malaria Control Programme
(NMCP) of Madagascar received international support
through funds from the Global Funds, the World Health
Organization and the US President’s Malaria Initiative as
help in their fight to eradicate malaria from the island
[7]. Nevertheless, only little is known on the recent epi-
demiology of P. falciparum infections in the country
[8,9]. Most studies were performed in symptomatic chil-
dren while parasite reservoirs in asymptomatic carriers
could hamper the progress of malaria control and eradica-
tion efforts. Therefore, active detection of infected carrier
could be useful for a malaria elimination programme [10].
This study explored the prevalence of asymptomatic
malaria carriers in two of the four epidemiological areas
in Madagascar. Blood samples collected in 2010 from
1,244 asymptomatic pregnant women from three coastal
and three highland cities were investigated for: (i) the
presence of malaria parasites, (ii) the seroprevalence of
anti-P. falciparum antibodies, (iii) the multiplicity of infec-
tion and (iv) the presence of drug resistance markers for
sulphadoxine-pyrimethamine (SP) and chloroquine (CQ).
Methods
Study sites
A cross-sectional survey was carried out between May
and July 2010 in antenatal clinics in six different loca-
tions (Figure 1). The Central highlands of Madagascar
are mainly on an altitude between 800 to 1,400 m above
sea level. The three highland cities included in this study
were Tsiroanomandidy (860 m), Moramanga (920 m),
and Ambositra (1,280 m). From the central highlands
the land descends over a steep fall into a ribbon of rainfor-
est that reaches to the east coast. Mananjary and Manakara
are on sea level at the east coast, and Ifanadiana is a 460 m
high settlement located on the steep slope from the east
coast to the highlands. The three first locations are later in
this report defined as the ‘highlands’ and the three last as
the ‘coast’. Mananjary and Manakara were affected by an
outbreak of chikungunya 3–5 months before this study
took place [11].
The study was approved by the “Comité d’éthique de
la Vice Primature Chargée de la Santé Publique” from
Madagascar. The study was explained to the pregnantwomen and their written informed consent was sought.
In case of illiteracy the study was explained and approval
of participation expressed through a fingerprint and sig-
nature of a witness.
Sample collection
A venous (EDTA) blood sample was taken and the plasma
was extracted by centrifugation. The supernatant was
stored at −20°C for serological analysis. Five hundred
microlitre of the pellet was taken and diluted with the
same amount of 8 M Urea solution (v/v) that is appro-
priate for conserving the sample at +4°C for later DNA
extraction.
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Serology for the detection of antibodies (IgG + IgA + IgM)
directed against Plasmodium falciparum was performed
by an in-house indirect immunofluorescence antibody test
(IFAT). Plasma samples were diluted to 1:40 with PBS plus
milk powder 3%. Twenty μL of the diluted plasma were
applied to an antigen field, and were incubated for 30 min
at 37°C. One positive control and one negative control
were included in each series. The slides were washed
three times for 5 min in PBS and dried before adding
fluorescein-labelled total human anti-Ig conjugate (Sifin,
Berlin, Germany) diluted at 1/200 in PBS containing Evans
blue (0.1 g/L). After incubation for 30 min at 37°C in a
humid chamber, the slides were again washed three times
for 5 min in PBS. The slides were read under a fluores-
cence microscope (Zeiss) with UV-illumination at a mag-
nification of 250. Samples fluorescing at 1/40 dilution
were considered positive. An exact titer of the positive
samples was not determined.
The in-house immunofluorescence test itself was man-
ufactured using the laboratory strain 3D7 as antigen.
The Plasmodium strain was cultured in red blood cells
obtained from German Red Cross Blood Bank as de-
scribed elsewhere [12]. Erythrocytes containing mature
parasite forms were purified using a commercially avail-
able magnetic cell fractionation system (MACS system;
Miltenyi Biotec). The purified erythrocytes were applied
to glass slides with 12 fields (Thermo Scientific, Dreieich,
Germany), air dried and stored at −70°C for long-term
storage and subsequently at −20°C few days before usage.
After thawing, the antigen slides were fixed in acetone/
methanol solution (v/v) for 5 min at 4°C.
Molecular genotyping
DNA extraction
DNA was extracted from 400 μL of peripheral venous
blood-EDTA/8 M urea (v/v) using the QIAamp® DNA
Blood mini Kit according to the manufacturer’s protocol
(Qiagen).
Molecular detection of malarial species
Four Plasmodium species with human as host were
assessed by real-time PCR methodology based on Fluores-
cence Resonance Energy Transfer technology. P. falcip-
arum was detected with primers and probes targeting the
cox1 gene and P. ovale, P. malariae and P. vivax with
primers and probes targeting the 18S rDNA (Additional
file 1).
On a LightCycler 480 (Roche), the PCR was carried
out in a total volume of 20 μL containing 5 μL of
extracted genomic DNA or plasmids including the gene
targeted for each species as positive control. The mix-
ture to detect P. falciparum contained 0.2 mM dNTPs,
3.5 mM MgCl2, 0.4 μM of forward primer, 0.5 μM ofreverse primer, 0.15 μM each of the donor and acceptor
probes, 0.25 g/l bovine serum albumin (BSA) and 0.5 U
Taq polymerase (Platinium, Invitrogen). The multiplex
PCR to detect P. malariae, P. ovale and P. vivax used
three forward primers; each primer is specific of one
species and one reverse primer for the three species.
The mixture differed from the first one by primer con-
centration: 0.7 μM of forward primer for P. malariae,
0.5 μM of each forward primer for P. ovale and P. vivax,
0.4 μM of reverse primer.
For both PCRs, the following PCR programme was
used: 2 min at 95°C; 10 touchdown repeated cycles of
5 sec at 95°C, 10 sec at 63°C to 58°C, 7 sec at 72°C; and 45
repeated cycle of 5 sec at 95°C, 10 sec at 58°C, 7 sec at 72°C.
Melting analysis was performed by denaturing for 30 sec
at 95°C and cooling for 2 min to 45°C followed by heating
at the rate of 0.1°C/s from 45°C to 75°C.
Assessing multiplicity of infection of Plasmodium falciparum
To determine the minimal number of distinguishable
clones per isolate, we genotyped 6 different neutral highly
polymorphic, microsatellites ARA2 (chr 11, Genbank ac-
cession no. X17484), PfPK2 (chr 12, X63648), TA60 (chr
13, AF010556), TA81 (chr 5, AF010510), TA87 (chr 6,
AF010571), Poly alpha (chr 4, L18785). The multiplicity
of infection (MOI) was quantified as the “highest number
of fragments” for one of the microsatellites genotyped.
The six microsatellite loci were amplified by semi-nested
PCR according to a previous publication [13] with few
modifications. Three outer PCR duplexes were performed
followed by six nested PCRs. Each outer PCR mixture
(50 μL) contained 6 μL of DNA, 3 mM MgCl2, 200 μM
dNTPs, 50 nM for each primer (4 in total for Poly-
alpha and TA60, TA81 and ARA2 or PfPK2 and TA87;
Additional file 1) and 1.25 U Taq polymerase (GoTaq,
Promega). The sequences of all primers used are shown
in Additional file 1. Cycling conditions were as follows:
2 min at 94°C; 25 repeated cycles of 30 sec at 94°C,
30 sec at 42°C, 30 sec at 40°C, 40 sec at 65°C; 2 min at
65°C. Each nested PCR mixture contained 1 μL of the
outer PCR, 2.5 mM MgCl2, 200 μM dNTPs, 150 nM for
each primer and 1 U Taq polymerase (GoTaq, Promega).
Cycling conditions were as follows: 2 min at 94°C; 25
repeated cycles of 20 sec at 94°C, 20 sec at 45°C and
30 sec at 65°C; 2 min at 65°C. Amplified fragments were
analysed on an ABI 3130 Genetic Analyzer and by Gen-
eMapper® software version 4.0 (Applied Biosystems) to
measure the variable length in the samples.
Detection of Plasmodium falciparum drug resistance markers
by nested PCR-RFLP
For this study, the polymorphism of pfdhfr at codons
N51I, C59R, S108N and I164L, pfdhps at codons A437G
and K540E, pfcrt at codon K76T and pfmdr1 at codon
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cause we suspected low parasitaemia, the outer PCR
mixtures were carried out in a total volume of 50 μL
containing 6 μL of template DNA. DNA from two P. fal-
ciparum strains (3D7, and W2mef) was used as controls
for the PCR and the digestion.
Sample size calculations
For this study, the aim was to detect at least one preg-
nant woman with malaria parasites if the real prevalence
was 2.5% with a 90% probability. Using binomial distri-
bution as a proxy for a hypergeometrical distribution,
the required sample size of 152 was calculated. There-
fore aimed to include at least 160 women per study site.
With 200 pregnant women per study site, the 90% prob-
ability to detect at least one parasitized women holds
even if the real prevalence is only 2%.
Statistical analysis
For the statistical analysis of the study univariate tests
were performed. All categorical variables were analysed
conducting Fisher’s exact tests. As a normal distribution
of the MOI could not be assumed Mann Whitney’s U
test and Kruskall Wallis test as the non-prarametric
equivalent to an ANOVA were conducted for this vari-
able. The two-sided significance level for all tests was set
to 0.05 and not adjusted for multiple testing as the study
was planned as a descriptive study.
Results
Overall, 1,244 pregnant women were included into the
study. In all study locations, the age distribution was right
skewed with a median age of 25 years (range 12–50). Sub-
sequently, different variables were analysed according to
two age groups defined as up to 19 years and, 20 years
and over. Nine out of 601 women questioned from the
highlands claimed to travel within the last half of a year
and only one of these travels was to a coastal location.
The proportion of primiparae was similar in the high-
lands and at the coast (28.4% and 30.3%, respectively).
The only noteworthy mosquito protective measures that
were used frequently were bed nets (70.3%). The useTable 1 Prevalence of primigravidae women, bed net use and
Coast H
Mananjary Manakara Ifanadiana T
N + (%) N + (%) N + (%) N
primigravidae 188 64 (34.4) 245 58 (23.7) 178 48 (27.0) 2
Bed net use 190 172 (90.5) 250 228 (91.2) 197 186 (94.4) 2
IPTp/SP 190 88 (46.3) 243 96 (39.5) 196 126 (64.3) 1
TDD, Tsiroanomandidy.
IPTp/SP, Intermittent Presumptive Treatment in pregnancy with sulphadoxine-pyrim
N, Number of participants who answered the questionnaire.
+, Number of primigravidae participants or participants who claimed to use bed neof bed nets was more common in the coastal cities of
Mananjary (90.5%), Manakara (91.2%) and Ifanadiana
(94.4%) compared to the highland cities of Tsironoaman-
didy (56.7%), Moramanga (67.0%) and Ambositra (21.5%).
Intermittent presumptive treatment in pregnancy (IPTp)
was reported by 41.3% overall. The proportion of women
who had received IPTp was higher at the coast than in the
highlands (p > 0.001) (Table 1).
Prevalence of anti-Plasmodium falciparum antibodies
The prevalence of antibodies directed to P. falciparum
was determined using an IFAT for 1216 samples where
serum or plasma was available. In the coastal areas, the
seroprevalence was very high with 95.6% of the samples
(Figure 2). The prevalence according to age categories
up to 19 years and, from 20 years and over were similar
with 93.7% and 95.9%, respectively. In the highlands, the
seroprevalence was slightly lower with 87.1% in Tsiroano-
mandidy and 84.8% in Moramanga. In those two locations,
the seroprevalence was also equivalent according to age
groups. In Ambositra, located higher than 1,280 m above
sea level, antibodies against P. falciparum were detected
only in 30.4% of the pregnant women. The seroprevalence
was lower in the pregnant group up to 19 years with
25.9% than in the group of 20 years and over with 30.4%.
Prevalence of infection
Of all 1,242 blood samples, 157 (12.6%) were PCR-
positive for P. falciparum, nine for P. malariae, one for
P. ovale and one for P. vivax; six mixed infections were
found (Table 2). With 14.8% the mean of infected preg-
nant women was higher at the coast than at highland loca-
tions (9.2%, p < 0.001). In Ifanadiana, which is situated
466 m above sea level on the ascend from the coastal
study sites to the highlands, prevalence of 9.6% was found,
slightly lower than two of the three sites in the highlands:
Tsironomandidy (10.3%) and Moramanga (13.6%).
At the coast, the prevalence of infection was lower in
pregnant women using prophylaxis than in women with-
out prophylaxis. With IPTp, the prevalence was 14.0% vs.
18.9% and with bed net use; it was 14.2% vs. 21.6%,
respectively (Table 3). For the analysis of the MOI and foruptake of IPTp at six locations in Madagascar
ighlands Total
DD Moramanga Ambositra
+ (%) N + (%) N + (%) N + (%)
02 63 (31.2) 196 66 (33.7) 190 49 (25.8) 1199 348 (29.0)
03 115 (56.7) 194 130 (67.0) 200 43 (21.5) 1234 874 (70.8)
98 95 (48.0) 191 89 (46.6) 190 5 (2.6) 1208 499 (41.3)
ethamine.
t or IPTp/SP as prophylaxes.
Figure 2 Seroprevalence of anti-Plasmodium falciparum antibodies in pregnant women in six locations of Madagascar. The altitude of each site is
indicated in brackets. The grey bars indicate the percentage of seropositive samples and the white bar the seronegative samples.
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samples that were mono-infected by P. falciparum were
included.
Multiplicity of infection
The six neutral microsatellites genotyped in this study
were highly polymorphic in the six locations with a
number of alleles from nine for ARA2 and TA60 to 14
for PfPK2. The MOI could be determined for 116/152
samples by at least one microsatellite. The highest max-
imal number of different parasite clones detected in one
pregnant woman was four in a costal location (Mananjary)
with PfPk2. The average number of different clones
found in infected pregnant woman was 1.4 and it was
higher at the coast level (1.5, 95% CI: 1.3-1.7) than in
the highlands (1.2, 95% CI: 1.0-1.3; p = 0.005) (Figure 3).
The prevalence of P. falciparum monoclonal infection was
61.8% at the coast against 85.4% in the highlands (p =
0.005) (Table 4). According to the group of age, the MOI
was higher in the group of pregnant women up to 19 years
with 1.55 than in the one from 20 and over with 1.3
(Table 5). The MOI was slightly higher in the group of
pregnant women who didn’t use IPTp than in the one








Number of samples n % n % n %
P. falciparum 25 12.8 51 20.5 19 9.6
P. malariae 0 - 5 2 3 1.5
P. ovale 0 - 0 - 1 0.5
P. vivax 0 - 0 - 0 -
Pf + Pm 0 - 3 1.2 1 0.5
Pm + Po 0 - 0 - 1 0.5
TDD, Tsiroanomandidy.
N, Number of EDTA-blood samples collected.
n, number of positive samples for Plasmodium species detection by realtime-PCR.1.06) and at the coast (1.52 vs. 1.44) (Table 5). Further-
more, the use of bed net was significantly associated with
the reduction of MOI (2 vs. 1.43, p = 0.028) in the coast
level (Table 5).
Prevalence of drug resistance markers
Overall 152 isolates were screened for eight drug resist-
ance markers against SP (dhfr N51I, C59R, S108N,
I164L and dhps A437G, K540E) and CQ (pfcrt K76T and
pfmdr1 N86Y); 118 (77.6%) samples were successful ge-
notyped for at least one of the eight markers. Figure 4
gives an overview of the proportional distributions of
wild type, mutant and mixed type in the different study
locations. The allele dhfr triple mutant 51I, 59R, 108N
were polymorphic only in Manakara and Tsiroanoman-
didy with a prevalence of 20% (6/30) and 25% (2/8), re-
spectively. The allele dhfr 164L was genotyped in three
samples from the coast. The allelic frequency of dhps
437G was variable among the different locations (p =
0.02). With 71.6%, the prevalence of the mutant was
higher at the coast compared to the highlands with
27.3% (p < 0.001). Overall positive samples for dhfr and
dhps genotyping (N = 93), 6 (6.5%) samples were carry-
ing the quadrupule mutant dhfr 51I, 59R, 108N + dhpsPCR in pregnant women at six locations of Madagascar







n % n % n % n %
21 10.3 27 13.6 14 7 157 12.6
1 0.5 0 - 0 - 9 0.7
0 - 0 - 0 - 1 0.1
1 0.5 0 - 0 - 1 0.1
1 0.5 0 - 0 - 5 0.4
0 - 0 - 0 - 1 0.1
Table 3 Effect of prevention used against malaria among pregnant women in Malagasy coast and highlands
Coast Highlands
N Pf + (%) OR [CI 95%] p* N Pf + (%) OR [CI 95%] p*
Gravidea 1 437 62 (14.2) 0.95 [0.57-1.58] 0.474 410 38 (9.3) 1.45 [0.84-2.52] 0.119
≥2 170 23 (13.5) 178 23 (12.9)
Bed net use no 51 11 (21.6) 0.57 [0.28-1.16] 0.09 309 32 (10.4) 0.93 [0.55-1.59] 0.452
yes 584 79 (13.5) 288 28 (9.7)
IPTp/SP no 317 60 (18.9) 0.43 [0.26-0.69] >0.001 390 37 (9.5) 1.26 [0.72-2.20] 0.253
yes 310 28 (9.0) 189 22 (11.6)
Pf+, Number of positive samples with Plasmodium falciparum by realtime-PCR.
OR, odd ratio.
IPTp/SP, Intermittent Presumptive Treatment in pregnancy with sulphadoxine-pyrimethamine.
*Fisher’s exact test.
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genes and the wild type allele of pfcrt K76 and dhps K540
were fixed in all location.
Discussion
This study on healthy pregnant women demonstrates that
P. falciparum parasites can be found in resident populations
of Madagascan lowlands and highlands. As classical micros-
copy has sensitivity limitations when parasite levels are
low [15], the epidemiological analysis was based on PCR.
Prevalence of infection and immunity
Even in the highest study location, 1,200 m above sea
level, 7% of healthy participants were P. falciparum
positive. The permanent presence of P. falciparum inFigure 3 Multiplicity of infection in different locations in Madagascar. The
interval (CI 95%) at each study sites (a) and between costal and highland stud
the highest number of clones found by one of the six microsatellites genotyp
(*Mann Whitney test, p = 0.005) but no significant difference was found betwhighland populations with very low levels of parasit-
aemia may maintain some level of partial immunity
in the population indicated by the high seropreva-
lence in the area around 900 m above sea level (with
87.1% in Tsiroanomandidy and 84.8% in Moramanga).
However, the weak clinical immunity together with a
relevant parasite reservoir could initiate malaria epi-
demics like in Ambositra (1200 m above sea level)
where the seroprevalence in pregnant women were
around 30% and seems to be contracted in older category
of age. Indeed, the malaria epidemics in the highlands
between 1986 and 1988 were devastating with around
70,000 to 100,000 deaths every year [2]. Therefore, a sig-
nificant frequency of submicroscopic malaria parasite car-
riage has to be considered for the planning of controlmean of the multiplicity of infection (MOI) and its 95% confidence
y sites in Madagascar (b). For each samples, the MOI was determined by
ed. The MOI was significantly higher in the coast than in the highlands
een each site (Kruskal Wallis test, p = 0.065).
Table 4 Polyclonality of malaria infection in six locations in Madagascar
Coast Highlands












n % n % n % n % n % n %
1 12 63.2 24 64.9 6 50 13 76.5 19 95 9 81.8
2 4 21.1 11 29.7 4 33.3 4 23.5 0 - 2 18.2
3 2 10.5 2 5.4 2 16.7 0 - 1 5 0 -
4 1 5.3 0 - 0 - 0 - 0 - 0 -
MOI [CI 95%] 1.6 [1.1-2.0] 1.4 [1.2-1.6] 1.7 [1.2-2.2] 1.2 [1.0-1.5] 1.1 [0.9-1.3] 1.2 [0.9 - 1.5]
TDD, Tsiroanomandidy.
MOI, multiplicity of infection.
N, Number of Plasmodium falicparum samples able to be genotyped for microsatellite loci.
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toes has been demonstrated also at submicroscopic gam-
etocyte densities [1,17].
Control of malaria in the highlands
In this study, the use of bed nets or chemoprophylaxis
was associated with a reduction of infections in partici-
pants from the coast. Currently, malaria control in the
Malagasy highlands is mainly based on indoor insecticide
spraying [7]. It cannot be excluded that parasites detected
in highland locations were acquired at the coast and then
imported as it occurs in the capital Antananarivo [18].
Nevertheless, the data indicate a certain level of transmis-
sion in the central highlands because only one of 601
women from the highlands travelled to a coastal location
within the last half of year. Transmission in the highlands
is supported by entomological surveys that have shown the
occurrence of malaria vectors, such as Anopheles gambiae,
at altitudes above 1,200 m [19].
Mutations providing resistance against chloroquine and
sulphadoxine-pyrimethamine
An unusual haplotype carrying the single nucleotide
polymorphism (SNP) I164L on the dhfr gene involved inTable 5 Effect of prevention used against malaria among
pregnant women on the MOI in Malagasy coast and
highlands
Coast Highlands
N MOI p* N MOI p*
Age <20 20 1.7 0.142 11 1.27 0.418
≥20 48 1.42 34 1.15
Bed net use no 9 2 0.028 28 1.14 0.605
yes 58 1.43 19 1.21
IPTp/SP no 48 1.52 0.71 29 1.21 0.229
yes 18 1.44 18 1.01
MOI, multiplicity of infection.
IPTp/SP, Intermittent Presumptive Treatment in pregnancy with sulphadoxine-
pyrimethamine.
*Mann Whitney test.pyrimethamine resistance was previously found only in
Madagascar [20]. This SNP was detected in three sam-
ples from pregnant woman out of 70 genotyped but
never in association with the triple mutation dhfr 51I,
59R, 108N that is associated with a high resistance of P.
falciparum against antifolate drugs [21]. On the other
hand, four samples carrying the quadruple mutant dhps
437G + dhfr 51I, 59R, 108N in Manakara (11.8%) and
two samples in Tsiroanomandidy (15.4%) were found.
Accumulation of mutations in these two genes is associ-
ated with in vivo SP resistance [22]. Similar findings were
previously reported from samples collected in Madagascar
from 2006 to 2008 [20]. Even if these findings are not
alarming, a constant monitoring of SP resistance is advis-
able because SP is the drug of choice for malaria preven-
tion in pregnancy.
Prevalence of the principal resistance marker for CQ
pfcrt 76T was low in Madagascar compared to continen-
tal Africa [23]. However, in vivo resistance to CQ in
Madagascar that is not associated with the mutation
pfcrt 76T but with the mutation pfmdr1 86Y was found
and perhaps yet unknown mechanism were involved
[24,25]. In our study we found that the prevalence of
pfmdr1 86Y was low compared to previous data [20,23-25]
maybe because of the change of the first line policy from
CQ to artemisinin combination therapy (ACT). Neverthe-
less, a recent publication [14] has shown that the wild-type
pfmdr1 N86 SNP is associated with recrudescence of mal-
aria infection after artemether-lumefantrine treatment in
Benin. Studies on emerging ACT resistance can provide
more information for the guideline of malaria treatment in
Madagascar.
Multiplicity of infection
Lower numbers of different parasite strains were found
in infected women from the highlands compared to the
coast. This was expected, as multiplicity is a function of
transmission likelihood. The average of two to four P.
falciparum strains in the two coastal areas are in accord-
ance with what was described in areas of moderate to
Figure 4 Distribution of Plasmodium falciparum drug resistance alleles in the coast (a) and in highlands (b) of Madagascar. pfcrt and pfmdr1
mutations are associated with chloroquine resistance, dhfr and dhps mutaions with sulphadoxine-pyrimethamine resistance. The white bars indicate
the proportion of samples with wild-type allele, the black bars the proportion samples with mutant allele and the grey bars the proportion samples
with both alleles. In brackets, N represents the number of Plasmodium falciparum samples able to be genotyped by PCR-RFLP for each study sites.
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with low endemicity are factors associated with emergence
of malaria drug resistance like in South America or South-
East Asia [27]. The findings presented here are based on a
relative homogeneous subgroup of the population at risk.
Similar studies including children and also other adults
are needed to get more information on asymptomatic
malaria parasite carriers at different altitudes.
Effect of preventive measures on parasite carriage
In this study, the use of chemoprophylaxis (IPTp/SP)
and vector control (bed net) was assessed among pregnant
women from costal and highland locations of Madagascar.
The use of those preventive measures against malaria was
associated with the reduction of around 50% falciparum
parasite carriage and also with the reduction of the num-
ber of clones of parasites in one infection, especially in the
coastal area where the population are targeted by the mass
distribution of long-lasting insecticidal nets and IPTp.
The findings of this study are in accordance with the
conclusion of the nationwide evaluation of malaria in-
fection and coverage of malaria control interventions inMadagascar, which took place in 2012–2013 [28]. Malaria
control interventions should consider the whole popula-
tion from the endemic area like the coast but also from
the highlands.
Conclusion
This study demonstrated that asymptomatic malaria pa-
rasite carriers occur in Madagascar up to altitudes of
1,200 m with seroprevalences under 50%. The constella-
tion of an existing reservoir and low immunity in the
population is prone for malaria epidemics. The prevalence
of drug resistance markers is still not alarming compared
to some areas in the African mainland but monitoring
might be valuable in Madagascar where malarial parasites
seem to have different drug resistance mechanism than in
other areas. As the Malagasy National Malaria Control
Programme is moving toward the elimination of malaria
in the highlands, monitoring of the existence of parasites
in asymptomatic individuals becomes more important.
More sensitive technology like PCR based diagnostic for
the detection of submicroscopic parasitemia provides use-
ful information for malaria control.
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